Business / Finance

RSS

Cambridge Theranostics' liquidators set deadline for offers

Cambridge Theranostics' liquidators have set a deadline of 9 December for offers for the company's business, which includes the intellectual property of its principal product, Ateronon.

21 Nov 2011

Gilead enters agreement for Pharmasset acquisition

Gilead Sciences, Inc. and Pharmasset, Inc. announced today that the companies have signed a definitive agreement under which Gilead will acquire Pharmasset for $137 per share in cash.

21 Nov 2011

Health Management enters into new credit facilities and closes $875M Notes offering

Health Management Associates, Inc. announced today that it entered into new credit facilities, including a $500 million senior secured revolving credit facility, a $725 million senior secured term loan A with a five year term and a $1.4 billion senior secured term loan B with a seven year term.

21 Nov 2011

Adeona to develop and commercialize DNA-based therapeutic for PAH using Intrexon technology

Adeona Pharmaceuticals, Inc., and the Human Therapeutics Division of Intrexon Corporation, announced today the formation of a global exclusive channel collaboration through which Adeona intends to develop and commercialize a DNA-based therapeutic using Intrexon's UltraVector platform and RheoSwitch Therapeutic System for the treatment of pulmonary arterial hypertension (PAH).

21 Nov 2011

InferX third quarter gross profit increases 75% to $283,806

InferX Corporation, a market leader in next generation Predictive Analytics products and solutions for the defense, healthcare and intelligence communities, today announced financial results for the third quarter of fiscal year 2011, which ended September 30, 2011.

21 Nov 2011

ShangPharma third quarter net revenues increase 24.7% to $28.8 million

ShangPharma Corporation, a leading China-based pharmaceutical and biotechnology research and development outsourcing company, today announced its unaudited financial results for the quarter ended September 30, 2011.

21 Nov 2011

Comprehensive Care nine month revenues increase 212% to $54,039,000

Comprehensive Care Corporation, a leading behavioral health, substance abuse and psychotropic pharmacy management services provider for managed care companies throughout the U.S., is pleased to announce that its revenues for the nine months ended September 30, 2011 increased 212 percent to $54,039,000 compared to $17,344,000 for the same period in 2010.

21 Nov 2011

$GE Healthcare, Neste Jacobs enter alliance to increase self-sufficiency in blood plasma fractionation$

GE Healthcare, Neste Jacobs enter alliance to increase self-sufficiency in blood plasma fractionation

GE Healthcare, the healthcare business of GE and Neste Jacobs, a leading global expert in plasma fractionation plant engineering design and construction, announced today that the companies have formed a strategic alliance to assist countries worldwide to become self-sufficient in the manufacture of blood plasma products.

21 Nov 2011

OTS to market and disribute RaySearch's RayStation in South Korea

...

21 Nov 2011

Valeant signs agreement to acquire iNova

Valeant Pharmaceuticals International, Inc. announced today that it has signed an agreement to acquire iNova, a private pharmaceutical group which sells and distributes a range of prescription and over-the-counter (OTC) products in Australia, New Zealand, Southeast Asia and South Africa from Archer Capital, Ironbridge and other minority management shareholders.

21 Nov 2011

New website helps small business owners to review health insurance plans

A greatly expanded website to give small business owners an unprecedented detailed review of their health insurance plan choices was announced today by the U.S. Department of Health and Human Services.

19 Nov 2011

Oxford closes $5M revolving line of credit with Mason Health

Oxford Finance LLC, a specialty finance firm that provides senior debt to life sciences and healthcare services companies, today announced that it closed a $5 million revolving line of credit with Mason Health. Proceeds of the loan are being used to refinance existing debt and to support the operation of multiple skilled nursing facilities throughout Texas.

19 Nov 2011

Shire, Shionogi enter agreement to co-develop and co-commercialize ADHD medicines in Japan

Shire plc, the global specialty biopharmaceutical company, announces that it has entered into an agreement with Shionogi & Co. Ltd. of Japan to co-develop and co-commercialize certain of Shire's Attention Deficit Hyperactivity Disorder (ADHD) medicines in Japan.

19 Nov 2011

Cyberonics net sales increase 13% to $53.7M for second quarter 2012

Cyberonics, Inc. today announced results for the quarter ended October 28, 2011.

19 Nov 2011

Puritan Medical Products establishes new diagnostic division

Responding to a fast-growing need for specialized diagnostic collection and transport systems, Puritan Medical Products LLC has established a new diagnostic division to better serve its customers throughout the world.

19 Nov 2011

Mobile robots need to be part of a 'whole-product solution'

Aldo Zini, president of the nation's leading developer of autonomous mobile robots in healthcare, told his fellow executives that mobile robots must be part of a "whole-product solution" if they are to gain relevance and acceptance in the market place.

19 Nov 2011

Pfizer receives 2011 Business Civic Leadership Center's Corporate Citizenship Award

Pfizer Inc. today announced that it has received the 2011 Business Civic Leadership Center's Corporate Citizenship Award in the Best International Ambassador category for Pfizer's Global Health Partnerships program.

19 Nov 2011

Overlake acquires Issaquah Medical Group

Overlake Hospital Medical Center is continuing to grow its network of primary care medical clinics on the Eastside with the acquisition of Issaquah Medical Group, now named Overlake Medical Clinics Gilman.

18 Nov 2011

Tikcro reports net loss of $1.0 million for third quarter 2011

Tikcro Technologies Ltd. today reported results for the third quarter and nine months ended September 30, 2011.

18 Nov 2011

HealthStream prices public offering of 3,250,000 shares of common stock

HealthStream, Inc., announced today that it has priced a public offering of 3,250,000 shares of its common stock, consisting of 3,100,000 shares to be sold by the Company and 150,000 shares to be sold by certain selling shareholders at a price of $16.25 per share.

18 Nov 2011